# Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD

> **NCT07051707** · NA · RECRUITING · sponsor: **Nuvaira, Inc.** · enrollment: 200 (estimated)

## Conditions studied

- COPD
- Chronic Obstructive Pulmonary Disease

## Interventions

- **DEVICE:** Targeted Lung Denervation (TLD)

## Key facts

- **NCT ID:** NCT07051707
- **Lead sponsor:** Nuvaira, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-24
- **Primary completion:** 2028-04-30
- **Final completion:** 2029-10-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-04-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07051707

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07051707, "Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07051707. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*